by Kirsten Chalmers | Aug 17, 2022 | Health technology assessment, Healthcare, Market access, NICE
Insights Unmet medical need and market access: enabler or barrier to innovation? Designed to help healthcare stakeholders identify more urgent health needs, the concept of “unmet medical need” is being increasingly applied formally and informally to set priorities...
by Anna Pagotto | Jul 6, 2021 | Market access, NICE, Oncology
Insights Market access for immuno-oncology (I-O) therapies in the UK The rapid development of immuno-oncology (I-O) therapies has transformed the cancer treatment landscape, but health technology assessment (HTA) agencies can decide against covering or reimbursing...
